welcome1

Sharesource will be performing scheduled maintenance from _START_ to _END_. During this time, the Sharesource website will not be accessible; however patients may proceed with treatments as planned. Treatment data from connected devices will be available after maintenance is complete. Any device programming may need to be done manually during this time.

Starting in the second half of 2024, Baxter’s Chronic Kidney Care and Acute Therapies businesses is expected to separate from the Baxter Group and become an independent company called Vantive. The timing of this change will vary across geographies and so, Baxter will, in some countries, continue to provide services related to the Sharesource platform. The company providing the Sharesource related services will process your personal information for the purposes and in line with the principles described in the below privacy notice, and the Services will continue to be governed by the referenced Terms & Conditions. For any questions related to your personal information, please contact: [email protected].